https://www.marketscreener.com/quote/stock/INVIVYD-INC-125541564/news/Adagio-Therapeutics-Announces-ADG20-adintrevimab-is-the-First-Monoclonal-Antibody-to-Meet-Primar-39910866/?utm_source=telegram&utm_medium=social&utm_campaign=share